{"id":5722,"date":"2015-08-31T00:00:00","date_gmt":"2015-08-30T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/en\/blog\/2020\/05\/01\/ics-is-the-most-important-national-healthcare-provider-in-biomedical-research\/"},"modified":"2020-05-05T09:44:29","modified_gmt":"2020-05-05T07:44:29","slug":"ics-is-the-most-important-national-healthcare-provider-in-biomedical-research","status":"publish","type":"post","link":"https:\/\/idibell.cat\/en\/2015\/08\/ics-is-the-most-important-national-healthcare-provider-in-biomedical-research\/","title":{"rendered":"ICS is the most important national healthcare provider in biomedical research"},"content":{"rendered":"
The Catalan Institute of Health (ICS) is the leading healthcare provider in the Spain regarding the quantity and the quality of the scientific articles that have been published. In 2014, researchers from the seven research centers linked to ICS published 3.835 articles in indexed scientific journals, which means, more than any other healthcare institution in Catalonia and Spain; this makes a total amount of 14,381.23 impact factor points: a marker of quality based on the frequency which a journal\u2019s articles are cited in scientific publications.<\/p>\n
The research institutes which are part of the hospitals and primary healthcare facilities of the institutions are the Bellvitge Biomedical Research Institute (IDIBELL) that manages the research carried out at Bellvitge and Viladecans\u2019 Hospitals, the research institute of the Vall d’Hebron Hospital (VHIR); <\/p>\n
Health Sciences Research Institute of the \u201cGerman Trias I Pujol\u201d Foundation (IGTP), Biomedical Research Institute of Lleida (IRBLleida), Pere Virgili Institute (IISPV): management of research at Hospital l\u2019Hospital Joan XXIII in Tarragona and Verge de la Cinta Hospital in Tortosa, Girona Biomedical Research Institute (IDIBGI), Primary Care Research Institute Jordi Gol (IDIAP Jordi Gol), Four of these institutes (VHIR, IDIBELL, IGTP AND IRBLleida) are accredited as biomedical research institutes by the Institute of Health Carlos III. <\/p>\n
These centers currently have 1,148 ongoing research and competitive projects and 2,467 clinical trials that reached 91 million of euros during 2014. The institutes filed<\/p>\n
40 patent applications last year and signed 94 contracts for research and development. <\/p>\n
The main research lines of the centers linked to ICS, among others, are: neuroscience, cancer, cardiovascular diseases, infectious pathology and transplant, inflammatory, chronic and degenerative diseases, respiratory diseases, epidemiology and public health. <\/p>\n
Research is, together with teaching, a basic foundation to improve health care assistance that users at ICS are receiving. This public organization supports research that can be useful to improve people\u2019s health. In order to achieve this aim in the most efficient way, the institutes linked to ICS are cooperating closely with each other as well as with other institutions of the health care system of Catalonia and Spain and with the main centers of biomedical research worldwide. This is a piece of data highlighted in the<\/p>\n